EcoDrugPlus

Lysyl Oxidase-Like 2

Ensembl ID : ENSPEMG00000016856
Gene Symbol: LOXL2
1 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSPEMG00000029509
Gene Symbol: LOC102918774
3 Cross references
218 Possible Orthologues:

Macrophage Stimulating 1 Receptor (C-Met-Related Tyrosine Kinase)

Ensembl ID : ENSPEMG00000003939
Gene Symbol: MST1R
1 Cross references
266 Possible Orthologues:

Maltase-Glucoamylase 2, Pseudogene

Ensembl ID : ENSPEMG00000028150
Gene Symbol: MGAM2-PS
1 Cross references
390 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSPEMG00000020371
Gene Symbol: MMP12
1 Cross references
550 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSPEMG00000011633
Gene Symbol: MMP13
3 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSPEMG00000014840
Gene Symbol: MMP14
3 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSPEMG00000023486
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSPEMG00000020327
Gene Symbol: MMP3
3 Cross references
492 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSPEMG00000021337
Gene Symbol: MMP7
1 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSPEMG00000022864
Gene Symbol: MMP8
1 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSPEMG00000023917
Gene Symbol: MMP9
3 Cross references
214 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).